Ted Love

(Dr. Ted Love M.D.)

Currently holds positions in Santarus Inc, Amicus Therapeutics Inc, Portola Pharmaceuticals Inc and Global Blood Therapeutics Inc

Positions
Position Company Period
Independent Director Santarus Inc March 18, 2005 -
Independent Director Amicus Therapeutics Inc June 13, 2012 -
Independent Director Portola Pharmaceuticals Inc Sept. 19, 2019 -
President, Chief Executive Officer, Director Global Blood Therapeutics Inc June 1, 2014 -
Independent Director Cascadian Therapeutics Inc Sept. 5, 2013 - March 9, 2018
Lead Independent Director Humanigen Inc May 28, 2015 - Nov. 19, 2015
Independent Chairman of the Board Humanigen Inc May 1, 2014 - May 28, 2015
Independent Director Humanigen Inc March 1, 2009 - May 1, 2014
Independent Director Savara Inc Sept. 5, 2012 - Aug. 7, 2013
Independent Director Bio Rad Laboratories Inc March 24, 2010 - April 23, 2013
Executive Vice President, Head - Research and Development and Technical Operations Onyx Pharmaceuticals Inc Jan. 1, 2011 - Aug. 1, 2012
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Total value Details
2020-04-29 2020-04-28
PS Planned sale
40,000 -3.7%
80.00
3,200,160 USD
40,000 -3.7% 80.00 3,200,160 USD
2020-04-29 2020-04-27
PS Planned sale
1,517 -0.1%
80.63
122,320 USD
1,517 -0.1% 80.63 122,320 USD
2020-04-29 2020-04-27
PS Planned sale
1,300 -0.1%
81.15
105,494 USD
1,300 -0.1% 81.15 105,494 USD
2020-02-20 2020-02-18
PS Planned sale
1,818 -0.2%
70.92
128,940 USD
1,818 -0.2% 70.92 128,940 USD
2020-02-20 2020-02-18
PS Planned sale
2,189 -0.2%
70.22
153,721 USD
2,189 -0.2% 70.22 153,721 USD
2020-01-23 2020-01-22
PS Planned sale
1,031 -0.1%
82.45
85,011 USD
1,031 -0.1% 82.45 85,011 USD
2020-01-23 2020-01-22
PS Planned sale
32,150 -2.9%
81.85
2,631,600 USD
32,150 -2.9% 81.85 2,631,600 USD
2020-01-23 2020-01-22
PS Planned sale
6,819 -0.6%
81.01
552,436 USD
6,819 -0.6% 81.01 552,436 USD
2020-01-23 2020-01-21
PS Planned sale
523 -0.0%
83.56
43,703 USD
523 -0.0% 83.56 43,703 USD
2020-01-23 2020-01-21
PS Planned sale
10,166 -0.9%
82.78
841,562 USD
10,166 -0.9% 82.78 841,562 USD
2020-01-23 2020-01-21
PS Planned sale
29,311 -2.6%
81.98
2,402,837 USD
29,311 -2.6% 81.98 2,402,837 USD